Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients
- 31 March 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 30 (3) , 219-227
- https://doi.org/10.1016/0165-0327(94)90082-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effectsEuropean Neuropsychopharmacology, 1993
- Can We Predict the Persistence of Depression?The British Journal of Psychiatry, 1992
- A meta-analysis of antidepressant outcome under "blinder" conditions.Journal of Consulting and Clinical Psychology, 1992
- Therapeutic Monitoring of Antidepressant DrugsTherapeutic Drug Monitoring, 1989
- Treatment of Resistant Depression Review on the efficacy of various biological treatments, specifically in major depression resistant to cyclic antidepressantsInternational Clinical Psychopharmacology, 1989
- Secondary and Meta-Analysis of the Efficacy of Non-Tricyclic AntidepressantsPharmacopsychiatry, 1988
- Oral Tyramine Pressor Test and the Safety of Monoamine Oxidase Inhibitor DrugsJournal of Clinical Psychopharmacology, 1988
- Results of an Open Clinical Trial of Brofaromine (CGP 11 305 A), a Competitive, Selective, and Short-Acting Inhibitor of MAO-A in Major Endogenous DepressionPharmacopsychiatry, 1987
- Prediction of Outcome in Depressive Illness by the Newcastle Diagnosis ScaleThe British Journal of Psychiatry, 1987
- Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-RespondersThe British Journal of Psychiatry, 1981